Latest News About Hepcidin Antimicrobial Peptide

I can’t reliably pull the very latest (right-now) news right now because my web-research access is unavailable in this moment. If you want, tell me whether you mean human hepcidin (HAMP), hepcidin-derived peptides, or fish hepcidins, and I’ll tailor a fresh “latest” sweep when access is available again.

Meanwhile, here are recent, credible research directions that are directly about hepcidin’s antimicrobial/antibacterial activity (not “breaking news,” but current scientific updates):

What’s been reported recently

• Hepcidin-derived peptides can show antibacterial effects and there’s active work on which hepcidin variants (e.g., “hamp1” vs “hamp2” in some fish models) have stronger activity and under what conditions. For example, a 2021 review discusses using hepcidins to prevent or treat bacterial infections and highlights differential activity between hepcidin variants, including infection models where one variant reduced mortality more than another.[3]
• Antimicrobial activity can be environment-dependent (e.g., pH). A review of hepcidins’ antimicrobial properties reports that acidic conditions can reduce antimicrobial concentrations and alter killing kinetics, while neutral conditions can support stronger killing behavior in certain experimental setups.[1]
• Newer studies continue identifying hepcidin antibacterial activity in non-mammalian species (e.g., fish), reinforcing that hepcidins/variants are part of broader innate-defense systems beyond the human liver context.[7]

If you want true “latest news”

Reply with one of these and I’ll focus the search: 1) Human hepcidin (HAMP) only
2) Hepcidin-derived antimicrobial peptides (therapeutic drug angle)
3) Aquaculture / fish hepcidins
4) All of the above

Also, tell me how you define “latest” (e.g., “past 7 days,” “past month,” or “2026 only”).